Who is sponsoring NCT05892367?

NCT05892367 is sponsored by Wilhelminenspital Vienna.

What drugs are being tested in NCT05892367?

Interventions in NCT05892367: Transbrachial Access for Interventions.

What condition does NCT05892367 study?

NCT05892367 studies Complication of Treatment.

Is NCT05892367 still recruiting?

NCT05892367 is currently completed. Last updated 7 June 2023.

Last reviewed 2023-06-07 · How we verify

NCT05892367: TBA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transbrachial Access for Interventions in Patients With Peripheral Arterial Occlusive Disease

Completed NA Last updated 7 June 2023

What this trial tests

NA trial testing Transbrachial Access for Interventions in Complication of Treatment in 95 participants. Completed in 2 October 2020.

Timeline

10 July 2018

Primary endpoint
21 August 2020

2 October 2020

Quick facts

Lead sponsor	Wilhelminenspital Vienna
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	95
Start date	10 July 2018
Primary completion	21 August 2020
Estimated completion	2 October 2020
Sites	1 location across Austria

Drugs / interventions tested

Transbrachial Access for Interventions

Conditions studied

Complication of Treatment — all drugs for Complication of Treatment →

Sponsor

Wilhelminenspital Vienna — full company profile →

Who can join

18 and older, any sex, with Complication of Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is an evaluation, whether an immobilization of the upper extremity by means of a positioning splint can help to reduce the incidence of local complications after transbrachial puncture for peripheral arterial interventions, or not.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Complication of Treatment

Currently open trials in the same condition.

NCT06563349 — Magnesium Sulfate in Children Undergoing Laparoscopic Appendectomy · Phase 4 · recruiting
NCT06451510 — Knee Osteoarthritis in the Region of Norrbotten · recruiting
NCT04615065 — Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine · recruiting

Other Wilhelminenspital Vienna trials

Trials by the same sponsor.

NCT05704140 — Vienna Vascular Access Studied on Exchange of Dialysis Catheters for Shunts Where Feasible · unknown
NCT03274531 — Pharmacists Intervention to Improve Hypertension Management in Primary Care · NA · completed
NCT03627455 — Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05892367 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wilhelminenspital Vienna
Last refreshed: 7 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05892367.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing